Michael T. Andriole - Net Worth and Insider Trading
Michael T. Andriole Net Worth
The estimated net worth of Michael T. Andriole is at least $5 Million dollars as of 2024-12-27. Michael T. Andriole is the CFO of Endocyte Inc and owns about 132,082 shares of Endocyte Inc (ECYT) stock worth over $3 Million. Michael T. Andriole is also the PRESIDENT AND CEO of Chimerix Inc and owns about 462,453 shares of Chimerix Inc (CMRX) stock worth over $2 Million. Details can be seen in Michael T. Andriole's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael T. Andriole has not made any transactions after 2024-08-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael T. Andriole
Michael T. Andriole Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael T. Andriole owns 2 companies in total, including Chimerix Inc (CMRX) , and Endocyte Inc (ECYT) .
Click here to see the complete history of Michael T. Andriole’s form 4 insider trades.
Insider Ownership Summary of Michael T. Andriole
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CMRX | Chimerix Inc | 2024-08-08 | Chief Business Officer |
| ECYT | Endocyte Inc | 2018-12-21 | Chief Financial Officer |
Michael T. Andriole Latest Holdings Summary
Michael T. Andriole currently owns a total of 2 stocks. Among these stocks, Michael T. Andriole owns 132,082 shares of Endocyte Inc (ECYT) as of October 9, 2018, with a value of $3 Million and a weighting of 66.45%. Michael T. Andriole also owns 462,453 shares of Chimerix Inc (CMRX) as of August 8, 2024, with a value of $2 Million and a weighting of 33.55%.
Latest Holdings of Michael T. Andriole
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ECYT | Endocyte Inc | 2018-10-09 | 132,082 | 23.99 | 3,168,647 |
| CMRX | Chimerix Inc | 2024-08-08 | 462,453 | 3.46 | 1,600,087 |
Holding Weightings of Michael T. Andriole
Michael T. Andriole Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael T. Andriole has made a total of 0 transactions in Endocyte Inc (ECYT) over the past 5 years. The most-recent trade in Endocyte Inc is the sale of 17,918 shares on October 9, 2018, which brought Michael T. Andriole around $278,804.
According to the SEC Form 4 filings, Michael T. Andriole has made a total of 4 transactions in Chimerix Inc (CMRX) over the past 5 years, including 2 buys and 2 sells. The most-recent trade in Chimerix Inc is the sale of 1,285 shares on August 8, 2024, which brought Michael T. Andriole around $1,067.
Insider Trading History of Michael T. Andriole
- 1
Michael T. Andriole Trading Performance
GuruFocus tracks the stock performance after each of Michael T. Andriole's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael T. Andriole is 60.17%. GuruFocus also compares Michael T. Andriole's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael T. Andriole within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael T. Andriole's insider trading performs compared to the benchmark.
Performance of Michael T. Andriole
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 18.7 | | | | | |
| Relative Return to S&P 500(%) | 15.55 | | | | | |
Michael T. Andriole Ownership Network
Michael T. Andriole Owned Company Details
What does Chimerix Inc do?
Who are the key executives at Chimerix Inc?
Michael T. Andriole is the Chief Business Officer of Chimerix Inc. Other key executives at Chimerix Inc include Principal Accounting Officer David Jakeman , director & Chief Executive Officer Michael A. Sherman , and 10 percent owner Cantex Pharmaceuticals, Inc. .
Chimerix Inc (CMRX) Insider Trades Summary
Over the past 18 months, Michael T. Andriole made 2 insider transaction in Chimerix Inc (CMRX) with a net sale of 3,029. Other recent insider transactions involving Chimerix Inc (CMRX) include a net purchase of 40,000 shares made by Fred A Middleton , a net sale of 6,270 shares made by David Jakeman , and a net sale of 1,940 shares made by .
In summary, during the past 3 months, insiders sold 0 shares of Chimerix Inc (CMRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 11,239 shares of Chimerix Inc (CMRX) were sold and 40,000 shares were bought by its insiders, resulting in a net purchase of 28,761 shares.
Chimerix Inc (CMRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Chimerix Inc Insider Transactions
Michael T. Andriole Mailing Address
Above is the net worth, insider trading, and ownership report for Michael T. Andriole. You might contact Michael T. Andriole via mailing address: C/o Endocyte, Inc., 3000 Kent Avenue, Suite A1-100, West Lafayette In 47906.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
